Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,215Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AbbVie Inc

02 9Allergan Aesthetics

03 2Bausch & Lomb Incorporated

04 2Bausch Health

05 4Chongqing Huapont Pharmaceutical

06 4Cosette Pharma

07 1DEEF Pharmaceutical

08 2Farmatek

09 1Fougera Pharmaceuticals Inc.

10 1Mayne Pharma

11 1Midas Care Pharmaceuticals

12 4Padagis

13 2Pierre Fabre

14 2Solaris Pharma

15 2Taro Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 1997-06-13

Application Number : 20600

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

02

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2000-09-29

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

03

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 1997-06-13

Application Number : 20600

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

04

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2000-09-29

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

05

TAZAROTENE

Brand Name : AVAGE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2002-09-30

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

06

Tazaroten

Brand Name : Zorac

Dosage Form : Gel

Dosage Strength : 0.0005

Packaging :

Approval Date : 22/08/1997

Application Number : 19970822000077

Regulatory Info : Deregistered

Registration Country : Sweden

Abbvie CB

07

Tazaroten

Brand Name : Zorac

Dosage Form : Gel

Dosage Strength : 0.10%

Packaging :

Approval Date : 22/08/1997

Application Number : 19970822000084

Regulatory Info : Deregistered

Registration Country : Sweden

Abbvie CB

08

Tazarotene

Brand Name : Zorac 0,05%

Dosage Form : GEL

Dosage Strength : 5mg/ml

Packaging : 30X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie CB

09

Tazarotene

Brand Name : Zorac 0,1%

Dosage Form : GEL

Dosage Strength : 1mg/g

Packaging : 30X1mg/g

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie CB

10

Tazarotene

Brand Name : Zorac 0.1% Gel

Dosage Form : Gel

Dosage Strength : 0.1%

Packaging :

Approval Date : 1998-07-01

Application Number : 61861

Regulatory Info : Cancelled

Registration Country : Spain

Abbvie CB

11

Tazarotene

Brand Name : Zorac 0.05% Gel

Dosage Form : Gel

Dosage Strength : 0.05%

Packaging :

Approval Date : 1998-07-01

Application Number : 61862

Regulatory Info : Cancelled

Registration Country : Spain

Abbvie CB

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

Brand Name : DUOBRII

Dosage Form : LOTION;TOPICAL

Dosage Strength : 0.01%;0.045%

Packaging :

Approval Date : 2019-04-25

Application Number : 209354

Regulatory Info : RX

Registration Country : USA

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : ARAZLO

Dosage Form : LOTION;TOPICAL

Dosage Strength : 0.045%

Packaging :

Approval Date : 2019-12-18

Application Number : 211882

Regulatory Info : RX

Registration Country : USA

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2017-12-22

Application Number : 208662

Regulatory Info : RX

Registration Country : USA

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2025-03-10

Application Number : 208662

Regulatory Info : RX

Registration Country : USA

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2019-01-28

Application Number : 211175

Regulatory Info : DISCN

Registration Country : USA

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : FABIOR

Dosage Form : AEROSOL, FOAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2012-05-11

Application Number : 202428

Regulatory Info : RX

Registration Country : USA

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2023-04-25

Application Number : 213079

Regulatory Info : RX

Registration Country : USA

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2023-04-25

Application Number : 213079

Regulatory Info : RX

Registration Country : USA

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2017-04-03

Application Number : 208258

Regulatory Info : RX

Registration Country : USA

blank